Skip to content

A Study to Describe Pediatric Influenza Vaccine Coverage

An Observational Study to Describe Pediatric Influenza Vaccine Coverage Among Pediatricians in the United States

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00639418
Enrollment
147494
Registered
2008-03-20
Start date
2007-08-31
Completion date
2011-06-30
Last updated
2014-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Brief summary

The purpose of this study is to describe flu vaccine coverage in children under 18 years of age and to examine correlations between in-office flu vaccine coverage and the use of various tactics to increase vaccine coverage.

Detailed description

To describe influenza vaccine coverage in children less than 18 years of age in practicing pediatricians' offices and family medicine physicians' offices and to examine correlations between in-office influenza vaccine coverage and the use of various tactics to increase vaccine coverage.

Interventions

BIOLOGICALInfluenza vaccination

This non-interventional study prospectively captured vaccine coverage and practices of participating physician offices through use of surveys during the influenza vaccination season.

Sponsors

MedImmune LLC
Lead SponsorINDUSTRY

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
6 Months to No maximum
Healthy volunteers
Yes

Inclusion criteria

Sites selected to participate were required to be able to accurately identify the number of patients under their care by age group and provide influenza vaccine at their location.

Design outcomes

Primary

MeasureTime frameDescription
Influenza Vaccine Coverage in Participants <18 Years of Age by Age Group in Pediatric PracticesSeasonal: 2007-2011Vaccine coverage was calculated from the number of participants vaccinated in each group, divided by the total number of participants under the practice's care in that specific age group.

Secondary

MeasureTime frameDescription
Compliance With the Recommended Two-dose Regimen in Vaccinated ParticipantsSeasonal: 2007-2011Compliance was calculated from the total number of participants receiving 2 doses divided by the total number of participants identified as requiring a second dose.
Correlation of Office Vaccination-related Attitudes and Activities With Actual Vaccine CoverageSeasonal: 2007-2011Correlation of office attitudes related to influenza vaccination and actual vaccine coverage was explored. Sites were asked to indicate level of agreement with the following recommendations: vaccinating children with high-risk medical conditions, patients 6 months to 5 years of age should be vaccinated against influenza each year, patients 5 to 18 years of age without high-risk medical conditions should be vaccinated against influenza each year, and previously unvaccinated patients less than 9 years of age receive 2 doses of vaccine.

Countries

United States

Participant flow

Recruitment details

This study of 118 physician offices in the USA identified the number of patients per practice by age group. A baseline survey and semi-monthly surveys of number of influenza vaccination doses given, staff attitudes toward influenza vaccination, and activities to increase influenza vaccination coverage were completed.

Pre-assignment details

While a total of 147494 children were vaccinated in participating physicians' offices, no subjects were actually treated in this observational study.

Participants by arm

ArmCount
Participants 6 to 23 Months
Pediatric influenza vaccine coverage within practicing pediatricians' offices for participants 6 to 23 months of age
28,101
Participants 24 to 59 Months
Pediatric influenza vaccine coverage within practicing pediatricians' offices for participants 24 to 59 months of age
35,967
Participants 5 to 8 Years
Pediatric influenza vaccine coverage within practicing pediatricians' offices for participants 5 to 8 years of age
36,496
Participants 9 to 18 Years
Pediatric influenza vaccine coverage within practicing pediatricians' offices for participants 9 to 17 years of age
46,930
Total147,494

Baseline characteristics

CharacteristicParticipants 6 to 23 MonthsParticipants 24 to 59 MonthsParticipants 5 to 8 YearsParticipants 9 to 18 YearsTotal
Age, Customized28101 participants35967 participants36496 participants46930 participants147494 participants
Sex: Female, Male
Female
NA ParticipantsNA ParticipantsNA ParticipantsNA ParticipantsNA Participants
Sex: Female, Male
Male
NA ParticipantsNA ParticipantsNA ParticipantsNA ParticipantsNA Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —— / —
other
Total, other adverse events
0 / 00 / 00 / 00 / 0
serious
Total, serious adverse events
0 / 00 / 00 / 00 / 0

Outcome results

Primary

Influenza Vaccine Coverage in Participants <18 Years of Age by Age Group in Pediatric Practices

Vaccine coverage was calculated from the number of participants vaccinated in each group, divided by the total number of participants under the practice's care in that specific age group.

Time frame: Seasonal: 2007-2011

ArmMeasureValue (NUMBER)
Participants 6 to 23 MonthsInfluenza Vaccine Coverage in Participants <18 Years of Age by Age Group in Pediatric Practices46.5 percentage of participants
Participants 24 to 59 MonthsInfluenza Vaccine Coverage in Participants <18 Years of Age by Age Group in Pediatric Practices30.9 percentage of participants
Participants 5 to 8 YearsInfluenza Vaccine Coverage in Participants <18 Years of Age by Age Group in Pediatric Practices30.6 percentage of participants
Participants 9 to 18 YearsInfluenza Vaccine Coverage in Participants <18 Years of Age by Age Group in Pediatric Practices19.4 percentage of participants
Secondary

Compliance With the Recommended Two-dose Regimen in Vaccinated Participants

Compliance was calculated from the total number of participants receiving 2 doses divided by the total number of participants identified as requiring a second dose.

Time frame: Seasonal: 2007-2011

ArmMeasureValue (NUMBER)
Participants 6 to 23 MonthsCompliance With the Recommended Two-dose Regimen in Vaccinated Participants67.5 percentage of participants
Participants 24 to 59 MonthsCompliance With the Recommended Two-dose Regimen in Vaccinated Participants42.7 percentage of participants
Participants 5 to 8 YearsCompliance With the Recommended Two-dose Regimen in Vaccinated Participants40.8 percentage of participants
Participants 9 to 18 YearsCompliance With the Recommended Two-dose Regimen in Vaccinated ParticipantsNA percentage of participants
Secondary

Correlation of Office Vaccination-related Attitudes and Activities With Actual Vaccine Coverage

Correlation of office attitudes related to influenza vaccination and actual vaccine coverage was explored. Sites were asked to indicate level of agreement with the following recommendations: vaccinating children with high-risk medical conditions, patients 6 months to 5 years of age should be vaccinated against influenza each year, patients 5 to 18 years of age without high-risk medical conditions should be vaccinated against influenza each year, and previously unvaccinated patients less than 9 years of age receive 2 doses of vaccine.

Time frame: Seasonal: 2007-2011

ArmMeasureValue (NUMBER)
Participants 6 to 23 MonthsCorrelation of Office Vaccination-related Attitudes and Activities With Actual Vaccine Coverage117 Sites
Participants 24 to 59 MonthsCorrelation of Office Vaccination-related Attitudes and Activities With Actual Vaccine Coverage118 Sites
Participants 5 to 8 YearsCorrelation of Office Vaccination-related Attitudes and Activities With Actual Vaccine Coverage118 Sites
Participants 9 to 18 YearsCorrelation of Office Vaccination-related Attitudes and Activities With Actual Vaccine Coverage117 Sites

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026